Light Mode
$0.0000 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0000, and at the day’s high of $0.0000
+0.00 (+0.00%) / 6M
Momentum, market sentiment, and recent alerts
INFIQ reads n/a: price sits above one of the two key moving averages.
No alerts for INFIQ in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing novel medicines for people with cancer. It focuses on its drug development segment. The company was founded by Steven H. Holtzman and Matthew D. Shair on March 22, 1995 and is headquartered in Cambridge, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.